Experienced in IgG4-Related Disease

Dr. Scott Lindhorst

Oncology | Neurology | Hematology Oncology
MUSC Health
University Medical Associates Of The Medical University Of South Carol
167 Ashley Ave, 
Charleston, SC 
Clinical Trials:Currently Recruiting for 2 Trials
Offers Telehealth

Experienced in IgG4-Related Disease
MUSC Health
University Medical Associates Of The Medical University Of South Carol
167 Ashley Ave, 
Charleston, SC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Scott Lindhorst is an Oncologist and a Neurologist in Charleston, South Carolina. Dr. Lindhorst is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, Brain Tumor, and Awake Craniotomy.

His clinical research consists of co-authoring 38 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Neurology
Hematology Oncology
Licenses
Internal Medicine in SC
Hospital Affiliations
Musc Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

UNIVERSITY MEDICAL ASSOCIATES OF THE MEDICAL UNIVERSITY OF SOUTH CAROL
167 Ashley Ave, Charleston, SC 29425
Call: 843-792-1414

Additional Areas of Focus

Dr. Lindhorst has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

A Phase III Trial of Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
A Phase III Trial of Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Enrollment Status: Recruiting
Publish Date: November 13, 2025
Intervention Type: Radiation, Procedure, Drug
Study Drug: Memantine
Study Phase: Phase 3
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Enrollment Status: Recruiting
Publish Date: November 10, 2025
Intervention Type: Other, Procedure, Radiation
Study Phase: Phase 3
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
Enrollment Status: Active_not_recruiting
Publish Date: November 28, 2025
Intervention Type: Other, Drug
Study Drugs: Temozolomide, Veliparib
Study Phase: Phase 2/Phase 3
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Procedure
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: October 31, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy
A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy
Enrollment Status: Completed
Publish Date: August 22, 2025
Intervention Type: Drug
Study Drug: Ramipril
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer
Enrollment Status: Terminated
Publish Date: July 17, 2025
Intervention Type: Other, Drug
Study Drug: Naloxegol
Study Phase: Phase 2
Olanzapine With or Without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial
Olanzapine With or Without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Enrollment Status: Active_not_recruiting
Publish Date: August 02, 2024
Intervention Type: Drug, Radiation
Study Drugs: Concomitant Temozolomide (TMZ), Procarbazine, Adjuvant Temozolomide (TMZ), CCNU, Vincristine
Study Phase: Phase 3
View 7 Less Clinical Trials

38 Total Publications

Leptomeningeal hemangioblastoma: illustrative case.
Leptomeningeal hemangioblastoma: illustrative case.
Journal: Journal of neurosurgery. Case lessons
Published: May 14, 2025
View All 38 Publications
Similar Doctors
Experienced in IgG4-Related Disease
Dr. Robert M. Carlile
Neurology
Experienced in IgG4-Related Disease
Dr. Robert M. Carlile
Neurology

Palmetto Primary Care Physicians

2500 Elms Center Road, 
North Charleston, SC 
 (14.9 miles away)
843-572-7727
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Robert Carlile is a Neurologist in North Charleston, South Carolina. Dr. Carlile is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Cerebellar Degeneration, Peripheral Neuropathy, Migraine, and Delirium.

Experienced in IgG4-Related Disease
Dr. Brian M. Lingerfelt
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Brian M. Lingerfelt
Hematology Oncology | Hematology | Oncology

Bon Secours St Francis Xavier Hospital Inc

2085 Henry Tecklenburg Dr, 
Charleston, SC 
 (5.8 miles away)
843-577-6957
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Brian Lingerfelt is a Hematologist Oncology specialist and a Hematologist in Charleston, South Carolina. Dr. Lingerfelt is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Hodgkin Lymphoma, Childhood Iron Deficiency Anemia, Familial Colorectal Cancer, and Paget Disease of the Breast. Dr. Lingerfelt is currently accepting new patients.

Experienced in IgG4-Related Disease
Dr. George F. Geils
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. George F. Geils
Hematology Oncology | Hematology | Oncology

Bon Secours St Francis Xavier Hospital Inc

2085 Henry Tecklenburg Dr, 
Charleston, SC 
 (5.8 miles away)
843-577-6957
Languages Spoken:
English
See accepted insurances
Accepting New Patients

George Geils is a Hematologist Oncology specialist and a Hematologist in Charleston, South Carolina. Dr. Geils is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Non-Hodgkin Lymphoma, Familial Colorectal Cancer, Colorectal Cancer, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Geils is currently accepting new patients.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lindhorst's expertise for a condition
ConditionClose
  • Elite
  • Astrocytoma
    Dr. Lindhorst is
    Elite
    . Learn about Astrocytoma.
    See more Astrocytoma experts
  • Brain Tumor
    Dr. Lindhorst is
    Elite
    . Learn about Brain Tumor.
    See more Brain Tumor experts
  • Glioblastoma
    Dr. Lindhorst is
    Elite
    . Learn about Glioblastoma.
    See more Glioblastoma experts
  • Glioma
    Dr. Lindhorst is
    Elite
    . Learn about Glioma.
    See more Glioma experts
  • Distinguished
  • Atypical Teratoid Rhabdoid Tumor (ATRT)
    Dr. Lindhorst is
    Distinguished
    . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
    See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
  • Embryonal Tumor with Multilayered Rosettes
    Dr. Lindhorst is
    Distinguished
    . Learn about Embryonal Tumor with Multilayered Rosettes.
    See more Embryonal Tumor with Multilayered Rosettes experts
  • Ependymoma
    Dr. Lindhorst is
    Distinguished
    . Learn about Ependymoma.
    See more Ependymoma experts
  • Gliosarcoma
    Dr. Lindhorst is
    Distinguished
    . Learn about Gliosarcoma.
    See more Gliosarcoma experts
  • Glomus Jugulare Tumor
    Dr. Lindhorst is
    Distinguished
    . Learn about Glomus Jugulare Tumor.
    See more Glomus Jugulare Tumor experts
  • Glomus Tympanum Tumor
    Dr. Lindhorst is
    Distinguished
    . Learn about Glomus Tympanum Tumor.
    See more Glomus Tympanum Tumor experts
View All 16 Distinguished Conditions
  • Advanced
  • Arachnoiditis
    Dr. Lindhorst is
    Advanced
    . Learn about Arachnoiditis.
    See more Arachnoiditis experts
  • Bone Tumor
    Dr. Lindhorst is
    Advanced
    . Learn about Bone Tumor.
    See more Bone Tumor experts
  • Brain Stem Cancer
    Dr. Lindhorst is
    Advanced
    . Learn about Brain Stem Cancer.
    See more Brain Stem Cancer experts
  • Breast Cancer
    Dr. Lindhorst is
    Advanced
    . Learn about Breast Cancer.
    See more Breast Cancer experts
  • Cerebral Ventricle Cancer
    Dr. Lindhorst is
    Advanced
    . Learn about Cerebral Ventricle Cancer.
    See more Cerebral Ventricle Cancer experts
  • Choroid Plexus Papilloma
    Dr. Lindhorst is
    Advanced
    . Learn about Choroid Plexus Papilloma.
    See more Choroid Plexus Papilloma experts
View All 24 Advanced Conditions
  • Experienced
  • Absence Seizure
    Dr. Lindhorst is
    Experienced
    . Learn about Absence Seizure.
    See more Absence Seizure experts
  • Acoustic Neuroma
    Dr. Lindhorst is
    Experienced
    . Learn about Acoustic Neuroma.
    See more Acoustic Neuroma experts
  • Adult Soft Tissue Sarcoma
    Dr. Lindhorst is
    Experienced
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • Agranulocytosis
    Dr. Lindhorst is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Aicardi-Goutieres Syndrome
    Dr. Lindhorst is
    Experienced
    . Learn about Aicardi-Goutieres Syndrome.
    See more Aicardi-Goutieres Syndrome experts
  • ALK-Positive Non-Small Cell Lung Cancer
    Dr. Lindhorst is
    Experienced
    . Learn about ALK-Positive Non-Small Cell Lung Cancer.
    See more ALK-Positive Non-Small Cell Lung Cancer experts
View All 98 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved